← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2018Last known activity
Sep 30, 2023
Timeline
2010s
- Jun 1, 2011
Recardio, Inc.— Founded
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT05881382Lead sponsorPhase 3Sep 30, 2023
- NCT03486080Study chairPhase 2Oct 31, 2018
- NCT03486080Lead sponsorPhase 2Oct 31, 2018
Details
- Founded
- San Francisco, CA, US Jun 1, 2011
- Last known activity
- Sep 30, 2023